Cargando…
Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates
Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...
Autores principales: | Du, Lizhong, Tong, Xiaomei, Chen, Chao, Gao, Xirong, Gagnatelli, Alessandra, Li, Jingyang, Santoro, Debora, Nicolardi, Sara, Fabbri, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078308/ https://www.ncbi.nlm.nih.gov/pubmed/32219085 http://dx.doi.org/10.3389/fped.2020.00076 |
Ejemplares similares
-
Specific Premature Groups Have Better Benefits When Treating Apnea With Caffeine Than Aminophylline/Theophylline
por: Lin, Yi-Chieh, et al.
Publicado: (2022) -
Evaluation of NAVA-PAP in premature neonates with apnea of prematurity: minimal backup ventilation and clinically significant events
por: Protain, Alison, et al.
Publicado: (2023) -
Treating Apnea of Prematurity
por: Pergolizzi, Joseph, et al.
Publicado: (2022) -
Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis
por: Miao, Yiqun, et al.
Publicado: (2022) -
Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022)